Literature DB >> 22457134

The theory of homogeny of liver and kidney in the treatment of kidney and liver fibrosis.

Ping Li1, Hao-Jun Zhang, Liu-Tao Zheng.   

Abstract

Chronic kidney disease (CKD) and chronic liver disease are both very harmful to human health almost all over the world, which lead to the fibrosis of the two organs ultimately. Currently, there are few satisfactory therapeutic methods in treating the two diseases. Some research works from Chinese medicine and Western medicine were done in the area recently, the results showed that kidney and liver fibrosis shared similar biological signals and events such as epithelial-mesenchymal transition (EMT) and transforming growth factor β 1, the same herbal mesenchymal medicine exhibited significantly improving effects on both liver fibrosis and kidney fibrosis by involving similar mechanism. This coincides with the theory of homogeny of Liver (Gan) and Kidney (Shen) of Chinese medicine. It would provides new clues in exploring the treatment of liver fibrosis and kidney fibrosis.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22457134     DOI： 10.1007/s11655-012-1063-5

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN： 1672-0415            Impact factor:   1.978


  10 in total

Review 1.  Mechanisms of hepatic fibrogenesis.

Authors:  Ursula E Lee; Scott L Friedman
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-04       Impact factor: 3.043

2.  Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis.

Authors:  Xiao Ming Meng; Xiao Ru Huang; Arthur C K Chung; Wei Qin; Xinli Shao; Peter Igarashi; Wenjun Ju; Erwin P Bottinger; Hui Yao Lan
Journal:  J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 10.121

3.  Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats.

Authors:  Yi-Maun Subeq; Chen-Yen Ke; Nien-Tsung Lin; Chung-Jen Lee; Yi-Han Chiu; Bang-Gee Hsu
Journal:  Cytokine       Date:  2010-12-03       Impact factor: 3.861

Review 4.  Topical herbal application as an adjuvant treatment for chronic kidney disease--a systematic review of randomized controlled clinical trials.

Authors:  Hongwei Zhang; Yi Fong Ho; Chun-Tao Che; Zhi-Xiu Lin; Connie Leung; Lai Sum Chan
Journal:  J Adv Nurs       Date:  2012-01-10       Impact factor: 3.187

5.  Therapeutic mechanism of Saikosaponin-d in anti-Thy1 mAb 1-22-3-induced rat model of glomerulonephritis.

Authors:  Ping Li; Yuewen Gong; Ning Zu; Yajun Li; Bin Wang; Fujio Shimizu
Journal:  Nephron Exp Nephrol       Date:  2005-08-11

6.  Chinese herbal formula Qilong-Lishui granule improves puromycin aminonucleoside-induced renal injury through regulation of bone morphogenetic proteins.

Authors:  Ping Li; Jing Yan; Yu Sun; Frank J Burczynski; Yuewen Gong
Journal:  Nephrology (Carlton)       Date:  2007-10       Impact factor: 2.506

7.  Pro-fibrogenic potential of PDGF-D in liver fibrosis.

Authors:  Erawan Borkham-Kamphorst; Claudia R C van Roeyen; Tammo Ostendorf; Jürgen Floege; Axel M Gressner; Ralf Weiskirchen
Journal:  J Hepatol       Date:  2007-02-23       Impact factor: 25.083

8.  Mechanism of saikosaponin-d in the regulation of rat mesangial cell proliferation and synthesis of extracellular matrix proteins.

Authors:  Ning Zu; Ping Li; Ning Li; Patrick Choy; Yuewen Gong
Journal:  Biochem Cell Biol       Date:  2007-04       Impact factor: 3.626

9.  Saikosaponin-d attenuates the development of liver fibrosis by preventing hepatocyte injury.

Authors:  Jianghong Fan; Xin Li; Ping Li; Ning Li; Tailing Wang; Hong Shen; Yaw Siow; Patrick Choy; Yuewen Gong
Journal:  Biochem Cell Biol       Date:  2007-04       Impact factor: 3.626

10.  Low-dose paclitaxel ameliorates fibrosis in the remnant kidney model by down-regulating miR-192.

Authors:  Lin Sun; Dongshan Zhang; Fuyou Liu; Xudong Xiang; Guanghui Ling; Li Xiao; Yinghong Liu; Xuejing Zhu; Ming Zhan; Yeyi Yang; Vinay K Kondeti; Yashpal S Kanwar
Journal:  J Pathol       Date:  2011-08-24       Impact factor: 7.996
  10 in total
  3 in total

Review 1.  Efficacy and safety of Flos Abelmoschus manihot (Malvaceae) on type 2 diabetic nephropathy: A systematic review.

Authors:  Yi-Zhi Chen; Zhi-Xiang Gong; Guang-Yan Cai; Qing Gao; Xiang-Mei Chen; Li Tang; Ri-Bao Wei; Jian-Hui Zhou
Journal:  Chin J Integr Med       Date:  2014-12-09       Impact factor: 1.978

2.  Difference of Liver and Kidney Metabolic Profiling in Chronic Atrophic Gastritis Rats between Acupuncture and Moxibustion Treatment.

Authors:  Qi-da He; Yuan-Peng Huang; Li-Bing Zhu; Jia-Cheng Shen; Lin-Yu Lian; Yuan Zhang; Long-Bin Zhang; Lin-Chao Qian; Xian-Jun Meng; Mi Liu; Cai-Chun Liu; Zong-Bao Yang
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-17       Impact factor: 2.629

3.  Research and application of herbal medicine in the treatment of chronic kidney disease since the 21st century: A visualized bibliometric analysis.

Authors:  Yunling Xu; Jia Chen; He Wang; Ying Lu
Journal:  Front Pharmacol       Date:  2022-09-30       Impact factor: 5.988
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.